close

Exactech, Inc. engages in the development, manufacture, marketing, distribution, and sale of orthopedic implant devices, related surgical instrumentation, and biologic services to hospitals and physicians in the United States and internationally. The company offers joint replacement systems, including knee, hip, spine, and extremity implant systems, as well as distributes biologic products and services, and bone cement materials used in orthopedic surgery and dental procedures. Its joint replacement products are used by orthopedic surgeons to repair or replace joints that have deteriorated as a result of injury or disease. The company's product portfolio comprises Optetrak knee system that serves orthopedic surgeons in contact stress, patellar tracking, polyethylene wear, joint stability, and bone preservation applications; Novation Hip Systems designed for various forms of hip replacements; and various other products for the healing and regeneration of bone and wound tissue. Its products also include the Cemex bone cement system, a self-contained delivery system, which integrates bone cement powder and liquid into a sealed mixing system; and InterSpace hip, knee, and shoulder spacers. The company offers its products through independent sales agencies, direct sales representatives, and distributors. It has a strategic partnership with Genzyme Biosurgery Corporation. The company was founded in 1985 and is headquartered in Gainesville, Florida.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	16.74
Volume	9376
Volume Avg	14637
52 Week High	19.00
52 Week Low	12.90
PE	25.04
PE (group average)	39
EPS Year	0.67
EPS change Q/Q	90.91%
EPS change Q/Q Yr ago	425%
EPS change Q/Q next Q est	-19.23%
EPS change Y/Y	-19.75%
REV change Q/Q	23.33%
REV change Q/Q Yr ago	7.25%
EPS next Q est	0.26
EPS next Y est	1.19
Divident Annual	0.00
Dividend Yield	0%